BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11493483)

  • 21. Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.
    Sandlund JT; Shurtleff SA; Onciu M; Horwitz E; Leung W; Howard V; Rencher R; Conley ME
    Pediatr Blood Cancer; 2013 Sep; 60(9):E85-7. PubMed ID: 23589280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent hypogammaglobulinemia following mononucleosis in boys is highly suggestive of X-linked lymphoproliferative disease--report of three cases.
    Hügle B; Suchowerskyj P; Hellebrand H; Adler B; Borte M; Sack U; Overberg-Schmidt US; Strnad N; Otto J; Meindl A; Schuster V
    J Clin Immunol; 2004 Sep; 24(5):515-22. PubMed ID: 15359110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No mutations of SAP/SH2D1A/DSHP and perforin genes in patients with Epstein-Barr virus-associated hemophagocytic syndrome in Japan.
    Ma X; Okamura A; Yosioka M; Ishiguro N; Kikuta H; Kobayashi K
    J Med Virol; 2001 Oct; 65(2):358-61. PubMed ID: 11536244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein-Barr virus-associated illnesses.
    Sumegi J; Seemayer TA; Huang D; Davis JR; Morra M; Gross TG; Yin L; Romco G; Klein E; Terhorst C; Lanyi A
    Leuk Lymphoma; 2002 Jun; 43(6):1189-201. PubMed ID: 12152986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. X-linked lymphoproliferative disease: three atypical cases.
    Nistala K; Gilmour KC; Cranston T; Davies EG; Goldblatt D; Gaspar HB; Jones AM
    Clin Exp Immunol; 2001 Oct; 126(1):126-30. PubMed ID: 11678908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. X-linked lymphoproliferative disease with a novel SH2D1A gene mutation.
    Debeljak M; Podkrajsek KT; Aplenc R; Jazbec J
    Pediatr Blood Cancer; 2008 Jan; 50(1):187. PubMed ID: 17455312
    [No Abstract]   [Full Text] [Related]  

  • 28. Follicular lymphoma in a X-linked lymphoproliferative syndrome carrier female.
    Woon ST; Ameratunga R; Croxson M; Taylor G; Neas K; Edkins E; Browett P; Gane E; Munn S
    Scand J Immunol; 2008 Aug; 68(2):153-8. PubMed ID: 18702745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients.
    Morra M; Simarro-Grande M; Martin M; Chen AS; Lanyi A; Silander O; Calpe S; Davis J; Pawson T; Eck MJ; Sumegi J; Engel P; Li SC; Terhorst C
    J Biol Chem; 2001 Sep; 276(39):36809-16. PubMed ID: 11477068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive molecular diagnosis of Epstein-Barr virus-associated lymphoproliferative diseases using next-generation sequencing.
    Ono S; Nakayama M; Kanegane H; Hoshino A; Shimodera S; Shibata H; Fujino H; Fujino T; Yunomae Y; Okano T; Yamashita M; Yasumi T; Izawa K; Takagi M; Imai K; Zhang K; Marsh R; Picard C; Latour S; Ohara O; Morio T
    Int J Hematol; 2018 Sep; 108(3):319-328. PubMed ID: 29777376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatal EBV infection and variable clinical manifestations in an XLP-1 pedigree - rapid diagnosis of primary immunodeficiencies may save lives.
    Sperl D; Benesch M; Urban C; Lackner H; Sovinz P; Speicher MR; Uhrig S; Schwarzbraun T; Schwinger W; zur Stadt U; Beutel K; Janka G; Scarpatetti M; Seidel MG
    Klin Padiatr; 2012 Oct; 224(6):386-9. PubMed ID: 23143765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural basis for SH2D1A mutations in X-linked lymphoproliferative disease.
    Lappalainen I; Giliani S; Franceschini R; Bonnefoy JY; Duckett C; Notarangelo LD; Vihinen M
    Biochem Biophys Res Commun; 2000 Mar; 269(1):124-30. PubMed ID: 10694488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
    Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
    Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
    Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
    Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
    [TBL] [Abstract][Full Text] [Related]  

  • 35. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
    Tangye SG
    J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked lymphoproliferative syndrome presenting with systemic lymphocytic vasculitis.
    Kanegane H; Ito Y; Ohshima K; Shichijo T; Tomimasu K; Nomura K; Futatani T; Sumazaki R; Miyawaki T
    Am J Hematol; 2005 Feb; 78(2):130-3. PubMed ID: 15682426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family.
    Lewis J; Eiben LJ; Nelson DL; Cohen JI; Nichols KE; Ochs HD; Notarangelo LD; Duckett CS
    Clin Immunol; 2001 Jul; 100(1):15-23. PubMed ID: 11414741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of SH2D1A in five classical Hodgkin's disease-derived cell lines.
    Kis LL; Nagy N; Klein G; Klein E
    Int J Cancer; 2003 May; 104(5):658-61. PubMed ID: 12594824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case Report: Meningoencephalitis With Thrombotic Occlusive Vasculopathy in a Young EBV-Naïve Boy Is Associated With a Novel
    Steininger J; Rossmanith R; Geier CB; Leiss-Piller A; Thonhauser L; Weiss S; Hainfellner JA; Freilinger M; Schmidt WM; Eibl MM; Wolf HM
    Front Immunol; 2021; 12():747738. PubMed ID: 34987501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
    Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
    PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.